In a cohort study conducted by Kim et al. [22] between 2006 and 2011, on 243 CKD patients, the sKl levels were significantly decreased while the FGF23 levels were increased in advanced CKD stages. The gene discussed is FGF23; the disease is chronic kidney disease.